Intracranial angioplasty & stenting for cerebral atherosclerosis: A position statement of the American Society of Interventional and Therapeutic Neuroradiology, Society of Interventional Radiology, and the American Society of Neuroradiology

American Journal of Neuroradiology

Volumn 26, Issue 9, 2005, Pages 2323-2327

  Higashida, Randall T ^a   Meyers, Philip M ^b   Connors III, John J ^c   Sacks, David ^d   Strother, Charles M ^e   Barr, John D ^f   Wojak, Joan C ^g   Duckwiler, Gary R ^h  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NewYork Presbyterian Hospital   (United States)

^c BAPTIST HOSPITAL OF MIAMI   (United States)

^d READING HOSPITAL AND MEDICAL CENTER   (United States)

^e HOUSTON METHODIST HOSPITAL   (United States)

^f BAPTIST MEMORIAL HOSPITAL   (United States)

^g Our Lady of Lourdes Regional Medical Center   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIINFLAMMATORY AGENT; ANTIMITOTIC AGENT; ANTITHROMBOCYTIC AGENT; HEPARIN; PACLITAXEL; RAPAMYCIN; WARFARIN;

ABSENCE OF SIDE EFFECTS; ANGIOPLASTY; ARTERY DISSECTION; ARTERY OCCLUSION; BALLOON DILATATION; BLEEDING; BRAIN ATHEROSCLEROSIS; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; DRUG ELUTING STENT; EXTRAINTRACRANIAL ANASTOMOSIS; HUMAN; INTERVENTIONAL RADIOLOGY; MEDICAL SOCIETY; NEURORADIOLOGY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; RESTENOSIS; REVIEW; RISK FACTOR; STENT; STROKE; THROMBOSIS; ARTICLE; PRACTICE GUIDELINE;

ANGIOPLASTY, BALLOON; HUMANS; INTRACRANIAL ARTERIOSCLEROSIS; STENTS;

EID: 32944456061     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (49)

1. Taylor TN, Davis PH, Torner JC, Holmes J, Meyer JW, Jacobson MF. Lifetime cost of stroke in the United States. Stroke 1996;27:1459-1466
2. Heart Disease and Stroke Statistics-2001 Update. Dallas: American Heart Association, 2004
3. Caplan LR, Gorelick PB, Hier DB. Rate, sex and occlusive cerebrovascular disease: A review. Stroke 1986;17:648-655
4. Craig DR, Meguro K, Watridge C, Robertson JT, Barnett HJ, Fox AJ. Intracranial internal carotid artery stenosis. Stroke 1982;13: 825-828
5. Wityk RJ, Lehman D, Klag M, Coresh J, Ahn H, Litt B. Race and sex differences in the distribution of cerebral atherosclerosis. Stroke 1996;27:1974-1980
6. Ingall TJ, Homer D, Baker HL Jr, Kottke BA, O'Fallon WM, Whisnant JP. Predictors of intrucranial carotid artery atherosclerosis. Duration of cigarette smoking and hypertension are more powerful than serum lipid levels. Arch Neurol 1991;48:687-691
7. Inzitari D, Hachinski VC, Taylor DW, Barnett HJ. Racial differences in the anterior circulation in cerdbrovascular disease. How much can be explained by risk factors? Arch Neurol 1990;47:1080-1084
8. Fisher CM. Cerebral arterial occlusion-remarks on pathology, pathophysiology, and diagnosis. Clin Neurosurg 1963;9:88-105
9. Derdeyn CP, Grubb RL Jr, Powers WJ. Cerebral hemodynamic impairment: Methods of measurement and association with stroke risk. Neurology 1999;53:251-259
10. Naritomi H, Sawada T, Kuriyama Y, Kinugawa H, Kaneko T, Takamiya M. Effect of chronic middle cerebral artery stenosis on the local cerebral hemodynamics. Stroke 1985;16:214-219
11. Grubb RL Jr, Derdeyn CP, Fritsch SM, et al. Importance of hemodynamic factors in the prognosis of symptomatic carotid occlusion. JAMA 1998;280:1055-1060
12. Constantinides P. Pathogenesis of cerebral artery thrombosis in man. Arch Pathol 1967;83:422-428
13. Caplan LR. Intracranial branch atheromatous disease: A neglected, understudied, and underused concept. Neurology 1989;39:1246-1250
14. Bogousslavsky J, Barnett HJ, Fox AJ, Hachinski VC, Taylor W. Atherosclerotic disease of the middle cerebral artery. Stroke 1986;17:1112-1120
15. Chimowitz MI, Kokkinos J, Strong J, et al. The Warfarin-Aspirin Symptomatic Intracranial Disease Study. Neurology 1995;45: 1488-1493
16. Thijs VN, Albers GW. Symptomatic Intracranial atherosclerosis: Outcome of patients who fail antithrombotic therapy. Neurology 2000;55:490-497
17. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. New Engl J Med 2005;352:1305-1316
18. Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke. Results of an international randomized trial. The EC/IC Bypass Study Group. N Engl J Med 1985;313: 1191-1200
19. Rundek T, Elkind MS, Chen X. Increased early stroke recurrence among patients with extracranial and intracranial atherosclerosis: Northern Manhattan Stroke Study. Neurology 1998:50(suppl. 4);A75
20. Prognosis of patients with symptomatic vertebral or basilar artery stenosis. The Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) Study Group. Stroke 1998;29:1389-1392
21. Caplan LR. Advances in stroke research: Basic science, treatment, and clinical trial outcomes. Rev Neurol Dis 2004;2:91-94
22. Terada T, Higashida RT, Halbach VV, et al. Transluminal angioplasty for arteriosclerotic disease of the distal vertebral and basilar arteries. J Neurol Neurosurg Psychiatry 1996;60:377-381
23. Higashida RT, Tsai FY, Halbach VV, et al. Transluminal angioplasty for atherosclerotic disease of the vertebral and basilar arteries. J Neurosurg 1993;78:192-198
24. Higashida RT, Tsai FY, Halbach VV, Dowd CF, Hieshima GB. Transluminal angioplasty, thrombolysis, and stenting for extracranial and intracranial cerebral vascular disease. J Intervent Cardiol 1996;9:245-256
25. Higashida RT, Hieshima GB. Tsai FY, Halbach VV, Norman D, Newton TH. Transluminal angioplasty of the vertebral and basilar artery. AJNR Am J Neuroradiol 1987;8:745-749
26. Stenting of Symptomatic Atherosclerotic Lesions in the Vertebral or Intracranial Arteries (SSYLVIA): Study results. Stroke 2004;35: 1388-1392
27. Phatouros CC, Higashida RT, Malek AM, et al. Endovascular stenting of an acutely thrombosed basilar artery: Technical case report and review of the literature. Neurosurgery 1999;44:667-673
28. Phatouros CC, Lefler JE, Higashida RT, et al. Primary stenting for high-grade basilar artery stenosis. AJNR Am J Neuroradiol 2000;21:1744-1749
29. Malek AM, Higashida RT, Phatouros CC, et al. Treatment of posterior circulation ischemia with extracranial percutaneous balloon angioplasty and stent placement. Stroke 1999;30:2073-2085
30. Gress DR, Smith WS, Dowd CF, Halbach VV, Finley RJ. Higashida RT. Angioplasty for intracranial symptomatic vertebrobasilar ischemia. Neurosurgery 2002;51:23-27, discussion 27-29
31. Schumacher HC, Khaw AV, Meyers PM, Gupta R, Higashida RT. Intracranial angioplasty and stent placement for cerebral atherosclerosis. J Vasc Interv Radiol 2004:15(1 Pt 2):S123-132
32. Lopes DK, Ringer AJ, Boulos AS, et al. Fate of branch arteries after intracranial stenting. Neurosurgery 2003;52:1275-1278. discussion 1278-1279
33. Levy EI, Horowitz MB, Koebbe CJ, et al. Transluminal stent-assisted angioplasty of the intracranial vertebrobasilar system for medically refractory, posterior circulation ischemia: Early results. Neurosurgery 2001;48:1215-1221. discussion 1221-1223
34. Qureshi AI, Ziai WC, Yahia AM, et al. Stroke-free survival and its determinants in patients with symptomatic vertebrobasilar stenosis: A multicenter study. Neurosurgery 2003;52:1033-1039, discussion 1039-1040
35. Alazzaz A, Thornton J, Aletich VA, Debrun GM, Ausman JI, Charbel F. Intracranial percutaneous transluminal angioplasty for arteriosclerotic stenosis. Arch Neurol 2000;57:1625-1630
36. Eckard DA, Zarnow DM, McPherson CM, et al. Intracranial internal carotid artery angioplasty: Technique with clinical and radiographic results and follow-up. AJR Am J Radiol 1999;172:703-707
37. Mori T, Kazita K, Chokyu K, Mima I. Mori K. Short-term arteriographic and clinical outcome alter cerebral angioplasty and stenting for intracranial vertebrobasilar and carotid atherosclerotic occlusive disease. AJNR Am J Neuroradiol 2000;21:249-254
38. Mori T, Mori K, Fukuoka M, Arisawa M, Honda S. Percutaneous transluminal cerebral angioplasty: serial angiographic follow-up after successful dilatation. Neuroradiol 1997;39:111-116
39. Gomez CR, Misni VK, Liu MW, et al. Elective stenting of symptomatic basilar artery stenosis. Stroke 2000;31:95-99
40. Marks MP, Marcellus M, Norbash AM, Steinberg GK, Tong D, Albers GW. Outcome of angioplasty for atherosclerotic intracranial stenosis. Stroke 1999;30:1065-1069
41. Connors JJ 3rd, Wojak JC. Percutaneous transluminal angioplasty for intracranial atherosclerotic lesions: Evolution of technique and short-term results. J Neurosurg 1999;91:415-423
42. Nahser HC, Henkes H, Weber W, Berg-Dammer E, Yousry TA, Kuhne D. Intracranial vertebrobasilar stenosis: Angioplasty and follow-up. AJNR Am J Neuroradiol 2000;21:1293-1301
43. Yu W, Smith WS, Singh V, et al. Long-term outcome of endovascular stenting for symptomatic basilar artery stenosis. Nerology 2005;64:1055-1057
44. Marks MP, Marcellus ML, Do HM, et al. Intracranial angioplasty without stenting for symptomatic atherosclerotic stenosis: Long-term follow-up. AJNR Am J Neuroradiol 2005;26:525-530
45. Wojak JC, Dunlap DC, Hargrave KR, DeAlvare LA, Culbertson HS, Connors JJ 3rd. Intracranial angioplasty and stenting: Long-term results from a single center. Submitted to AJNR Am J Neuroradiol, 2005
46. Henkes H, Miloslavski E, Lowens S, Reinartz J, Liebig T, Kuhne D. Treatment of intracranial atherosclerotic stenoses with balloon dilatation and self-expanding stent deployment (WingSpan). Neuroradiology 47:222-228
47. Bosc A. The Wingspan Study. Presented at the American Society of Neuroradiology 43rd Annual Meeting, Toronto, Canada. May 23-27, 2005
48. Kirmani JF, Harris-Lane P, Divani AA, et al. Initial experience with drug eluting stents for symptomatic intracranial stenosis. Program and abstracts of the American Academy of Neurology 57th Annual Meeting; April 9-16, 2005: Miami Beach, Florida, [P03.071].
49. Biller J, Feinberg WM, Castaldo JE, et al. Guidelines for Carotid Endarterectomy: A Statement for Healthcare Professionals from a Special Writing Group of the Stroke Council, American Heart Association. Stroke. Feb 1998;29:554-562.